p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci172760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Hidetoshi Tsuda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inflammation & Immunity, Lerner Research Institute, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Interleukin-15. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIAID.
Abstract (Originalsprache)
Virus-induced memory T cells often express functional cross-reactivity, or heterologous immunity, to other viruses and to allogeneic MHC molecules that is an important component of pathogenic responses to allogeneic transplants. During immune responses, antigen-reactive naive and central memory T cells proliferate in secondary lymphoid organs to achieve sufficient cell numbers to effectively respond, whereas effector memory T cell proliferation occurs directly within the peripheral inflammatory microenvironment. Mechanisms driving heterologous memory T cell proliferation and effector function expression within peripheral tissues remain poorly understood. Here, we dissected proliferation of heterologous donor-reactive memory CD8 + T cells and their effector functions following infiltration into heart allografts with low or high intensities of ischemic inflammation. Proliferation within both ischemic conditions required p40 homodimer–induced IL-15 transpresentation by graft DCs, but expression of effector functions mediating acute allograft injury occurred only in high-ischemic allografts. Transcriptional responses of heterologous donor-reactive memory CD8 + T cells were distinct from donor antigen–primed memory CD8 + T cells during early activation in allografts and at graft rejection. Overall, the results provide insights into mechanisms driving heterologous effector memory CD8 + T cell proliferation and the separation between proliferation and effector function that is dependent on the intensity of inflammation within the tissue microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inflammation & Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
- Transplant Center, Cleveland Clinic, Cleveland, Ohio, USA.
- Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Förderung
- NIAID NIH HHS
- NIAID
Zitieren
APA
Tsuda, H., Keslar, K. S., Baldwin, W. M., Heeger, P. S., Valujskikh, A., & Fairchild, R. L. (2024). p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation. Journal of Clinical Investigation. https://doi.org/10.1172/jci172760
Vancouver
Tsuda H, Keslar KS, Baldwin WM, Heeger PS, Valujskikh A, Fairchild RL. p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation. Journal of Clinical Investigation. 2024. doi:10.1172/jci172760
BibTeX
@article{Tsuda2024,
author = {Tsuda, Hidetoshi and Keslar, Karen S and Baldwin, William M and Heeger, Peter S and Valujskikh, Anna and Fairchild, Robert L},
title = {p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci172760}
}
EUVIMED